


Locus Biosciences Revenue
Biotechnology Research • Morrisville, North Carolina, United States • 51-100 Employees
Locus Biosciences revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $51,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | $35,000,000 |
Key Contacts at Locus Biosciences
Nick Conley
Chief Technology Officer
Frank Gillam
Director, Ms&T
Taylor Penke
Director Of Automation And Informatics
Hannah Tuson
Director Of Discovery
Lana Mcmillan
Director Of R&D
Robert Mckee
Director Of Discovery
Nathan Macgregor
Associate Director Of Quality
Company overview
| Headquarters | 523 Davis Dr, Morrisville, North Carolina 27560, US |
| Phone number | +19193139648 |
| Website | |
| SIC | 873 |
| Keywords | Biotechnology, Automation, Artificial Intelligence, Synthetic Biology, Immunology, Microbiome, Antibiotic Resistance, Targeted Therapeutics, Bacterial Infections, Bacteriophage |
| Founded | 2015 |
| Employees | 51-100 |
| Socials |
Locus Biosciences Email Formats
Locus Biosciences uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@locus-bio.com), used 64.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@locus-bio.com | 64.9% |
{first name}.{last name} | john.doe@locus-bio.com | 32.4% |
{first initial} | j@locus-bio.com | 2.7% |
About Locus Biosciences
Locus Biosciences is a clinical-stage biotechnology company developing engineered bacteriophage products to address critical unmet medical needs in bacterial infections and immunology. The LOCUS platform combines predictive artificial intelligence and automated robotics to deliver optimized precision phage therapies that specifically kill target pathogens while leaving non-target bacteria (i.e., the rest of the patient’s microbiome) unaffected. Locus has strong backing from partners, having signed contracts with BARDA and CARB-X. The company recently completed the open-label portion of a Phase 2 trial assessing LBP-EC01 for the treatment of uncomplicated UTIs caused by drug-resistant E. coli.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Locus Biosciences has 26 employees across 8 departments.
Departments
Number of employees
Locus Biosciences Tech Stack
Discover the technologies and tools that power Locus Biosciences's digital infrastructure, from frameworks to analytics platforms.
Form builders
JavaScript libraries
JavaScript libraries
JavaScript libraries
CDN
Analytics
Font scripts
Databases
JavaScript libraries
Programming languages
Hosting
Frequently asked questions
4.8
40,000 users



